Tillmann, Hans L.

Publishing since 1994 (Senior)

Has published 125 publications in 17 years

Number of publications published per year by Tillmann, Hans L.. (Source : PubMed)

Distribution of publications types for Tillmann, Hans L.. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Tillmann HL, Wiese M, Braun Y, Weigand J, Tenckhoff S, Mössner J, Manns MP, Weissenborn K. Quality of life in patients with various liver diseases.  J. Viral Hepat.  2010  
•  McCarthy JJ, Li JH, Thompson A, Suchindran S, Lao XQ, Patel K, Tillmann HL, Muir AJ, McHutchison JG. Replicated Association Between an Interleukin-28B Gene Variant and a Sustained Response to Pegylated Interferon and Ribavirin.  Gastroenterology  2010  
•  Li JH, Qian Lao X, Tillmann HL, Rowell J, Patel K, Thompson A, Suchindran S, Muir AJ, Guyton JR, Gardner SD, McHutchison JG, McCarthy JJ. Interferon-lambda genotype and low serum low-density lipoprotein cholesterol levels in patients with chronic hepatitis C infection.  Hepatology  2010  
•  Heidrich B, Deterding K, Tillmann HL, Raupach R, Manns MP, Wedemeyer H. Virological and clinical characteristics of delta hepatitis in Central Europe.  J. Viral Hepat.  2009;16;12  
•  Wiegand J, Meya S, Schlaphoff V, Manns MP, Mössner J, Wedemeyer H, Tillmann HL. HBV-specific T-cell responses in healthy seronegative sexual partners of patients with chronic HBV infection.  J. Viral Hepat.  2009  
•  Mederacke I, Wedemeyer H, Ciesek S, Steinmann E, Raupach R, Wursthorn K, Manns MP, Tillmann HL. Performance and clinical utility of a novel fully automated quantitative HCV-core antigen assay.  J. Clin. Virol.  2009;46;3  
•  Schneider R, Bercker S, Schubert S, Tillmann HL, Fangmann J, Hauss J, Bartels M. Successful liver transplantation in antituberculosis therapy-induced acute fulminant hepatic failure.  Transplant. Proc.  2009;41;9  
•  Wiegand J, Patel K, Tillmann HL. Does hepatitis B surface antigen kinetics, including both decline and reaching a threshold, improve prediction of response?  Hepatology  2009;50;4  
•  Wiegand J, Luz B, Mengelkamp AK, Moog R, Koscielny J, Halm-Heinrich I, Susemihl C, Bentzien F, Diekmann J, Wernet D, Karger R, Angert K, Schmitt-Thomssen A, Kiefel V, Lutter K, Hesse R, Kätzel R, Opitz A, Luhm J, Barz D, Leib U, Matthes G, Tillmann HL. Autologous blood donor screening indicated a lower prevalence of viral hepatitis in East vs West Germany: epidemiological benefit from established health resources.  J. Viral Hepat.  2009;16;10  
•  Heringlake S, Schütte A, Flemming P, Schmiegel W, Manns MP, Tillmann HL. Presumed cryptogenic liver disease in Germany: High prevalence of autoantibody-negative autoimmune hepatitis, low prevalence of NASH, no evidence for occult viral etiology.  Z Gastroenterol  2009;47;5  

[ See timeline ] [ See all publications ]